News & Update

We are proud to announce that our Immunobooster Dailytab Gold has shown significant results in Clinical Trials conducted. The trials were conducted with normal healthy adults and severely affected COVID-19 patients. All patients recorded significant improvement in major health parameters and noticeably reduced symptoms. It was tested even on Severe ICU COVID-19 patients and reduced the duration of symptoms. Thanks and regards.